Sanqi Oral Solution Ameliorates Renal Ischemia/Reperfusion Injury via Reducing Apoptosis and Enhancing Autophagy: Involvement of ERK/mTOR Pathways

• Main Authors: Ruimin Tian (Author), Pinchao Wang (Author), Lihua Huang (Author), Chuang Li (Author), Zhaoyu Lu (Author), Zhisheng Lu (Author), Aijun Wu (Author), Kun Bao (Author), Wei Mao (Author), Qingming Huang (Author), Peng Xu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ischemia-reperfusion (I/R) induced acute kidney injury (AKI) is a significant health problem with high morbidity and mortality, yet prophylaxis strategies and effective drugs are limited. Sanqi oral solution (SQ) is a formulated medicine widely used in clinical settings to treat various renal diseas...